P

Inventor

BENNETT FRANK

US54 patents
⚠️ This page may combine multiple inventors who share the name “BENNETT FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

29 patents
US6800434B2Oct 5, 2004

Peptides as NS3-serine protease inhibitors of hepatitis C virus

SCHERING CORP89 citations97
US6403564B1Jun 11, 2002

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

SCHERING CORP122 citations97
US6277830B1Aug 21, 2001

5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon

SCHERING CORP120 citations97
US5661151AAug 26, 1997

Tetrahydrofuran antifungals

SCHERING CORP69 citations96
US7205330B2Apr 17, 2007

Inhibitors of hepatitis C virus NS3 protease

SCHERING CORP54 citations95
US7592316B2Sep 22, 2009

Peptides as NS3-serine protease inhibitors of hepatitis C virus

SCHERING CORP34 citations93
US5714490AFeb 3, 1998

Tetrahydrofuran antifungals

SCHERING CORP37 citations93
US5693626ADec 2, 1997

Tetrahydrofuran antifungals

SCHERING CORP24 citations93
US7192957B2Mar 20, 2007

Compounds as inhibitors of hepatitis C virus NS3 serine protease

SCHERING CORP28 citations92
US7186747B2Mar 6, 2007

Compounds as inhibitors of hepatitis C virus NS3 serine protease

SCHERING CORP47 citations92
US7173057B2Feb 6, 2007

Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus

SCHERING CORP44 citations92
US6894072B2May 17, 2005

Compounds as NS3-serine protease inhibitors of hepatitis C virus

SCHERING CORP59 citations92
US7425576B2Sep 16, 2008

Compounds as inhibitors of hepatitis C virus NS3 serine protease

SCHERING CORP20 citations91
US5516784AMay 14, 1996

Anti-HIV (AIDS) agents

SCHERING CORP26 citations90
US7423058B2Sep 9, 2008

Inhibitors of hepatitis C virus NS3 protease

SCHERING CORP15 citations83
US5710154AJan 20, 1998

Tetrahydrofuran antifungals

SCHERING CORP13 citations74
US5703236ADec 30, 1997

Tetrahydrofuran antifungals

SCHERING CORP11 citations74
US5703079ADec 30, 1997

Tetrahydrofuran antifungals

SCHERING CORP16 citations74
US7115578B2Oct 3, 2006

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

SCHERING CORP8 citations73
US6924270B2Aug 2, 2005

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

SCHERING CORP11 citations71
US7619094B2Nov 17, 2009

Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus

SCHERING CORP5 citations62
US6673775B2Jan 6, 2004

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

SCHERING CORP4 citations62
US6043245AMar 28, 2000

Tetrahydrofuran antifungal phosphate

SCHERING CORP3 citations62
US5693815ADec 2, 1997

Peptides

SCHERING CORP5 citations61
US7718691B2May 18, 2010

Compounds as inhibitors of hepatitis C virus NS3 serine protease

SCHERING CORP0 citations51
US7595299B2Sep 29, 2009

Peptides as NS3-serine protease inhibitors of hepatitis C virus

SCHERING CORP0 citations51
US5795874AAug 18, 1998

Water soluble antibiotics

SCHERING CORP0 citations51
US5652226AJul 29, 1997

Water soluble antibiotics

SCHERING CORP1 citations51
US7759499B2Jul 20, 2010

Compounds as inhibitors of hepatitis C virus NS3 serine protease

SCHERING CORP0 citations49

MERCK SHARP & DOHME

6 patents

DENDREON CORP

3 patents

GIRIJAVALLABHAN VINAY

3 patents

BENNETT FRANK

2 patents

ARASAPPAN ASHOK

2 patents

WALMART APOLLO LLC

2 patents

KWONG CECIL D

1 patent

SAKSENA ANIL K

1 patent

STEINBERG DAVID A

1 patent

Showing the top 50 of 54 patents by PatentIndex Score.